The Royal Orthopaedic Hospital
The Royal Orthopaedic Hospital NHS Foundation Trust (ROH) is one of Europe’s largest specialist orthopaedic units, offering a comprehensive range of treatments. The ROH currently performs the most elective orthopaedic procedures in the NHS.
Its dynamic portfolio of clinical trials and research programmes includes exploration of advanced therapies to regenerate diseased bone tissue; new prosthetics to restore normal joint function; and new pharmaceutical treatments which reduce the need for invasive surgery and speed up recovery.
It is also a renowned teaching and training trust, hosting students from Birmingham Medical School and Aston Medical School.
The ROH’s services are among the highest rated in the UK for both experience and clinical outcome; its research is ground-breaking; and its teaching programmes are moulding the next generation of leaders.
The research vision of the ROH is to ensure that every patient at the Royal Orthopaedic Hospital has the opportunity to take part in research. This requires Trust-wide engagement and integration of research into all clinical teams.
Research spotlight
The Dubrowsky Regenerative Medicine Laboratory
In 2014, former ROH patient, Mr Michael Dubrowsky passed away and left a significant legacy gift to the Trust following treatment he received here for chondrosarcoma. This generous gift enabled us to invest in a state-of-the-art regenerative medicine laboratory – The Dubrowsky Regenerative Medicine Laboratory. The laboratory was officially launched on 17 December 2019.
Research Tissue Bank
The ROH research tissue bank was established over twenty years ago and contains the world’s largest archive of frozen bone tumour samples. This unique research resource currently holds over 23,000 bone and muscle samples, including all orthopaedic malignancies as well as other benign and non-tumour tissue types. All samples are held within our secure and fully licenced facility at -80ﹾC with continual temperature monitoring.